Page last updated: 2024-08-24

zileuton and Cardiac Remodeling, Ventricular

zileuton has been researched along with Cardiac Remodeling, Ventricular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Z; Chen, JJ; Deng, W; Duan, M; Guo, Y; Liu, C; Tang, Q; Wang, J; Wu, QQ; Xiao, Y; Xie, S; Yuan, Y1

Other Studies

1 other study(ies) available for zileuton and Cardiac Remodeling, Ventricular

ArticleYear
The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPAR
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyurea; Lipoxygenase Inhibitors; Male; Mice; Myocytes, Cardiac; NF-E2-Related Factor 2; PPAR alpha; Rats; Signal Transduction; Ventricular Remodeling

2019